Steven A. Kriegsman, Director at RXI PHARMACEUTICALS CORP (RXII), sold 4,800 shares at $6.00 ($29K) on 2009-05-26, disclosed to the SEC on 2009-05-28.
Scheduled sale ($29k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CYTR | BUY | 2012-02-24 | $51K | — | Filing → |
| RXII | SELL | 2009-08-20 | $28K | — | Filing → |
| RXII | SELL | 2009-07-06 | $13K | — | Filing → |